Medicare Drug Screen: Don't Expect Medicare To Pay For 80100, 80101, or 80104

Why This Topic Matters

Medicare drug screen claims can be denied or edited if they are reported under the wrong code family or without attention to CLIA status, units, bundling, and modifier requirements. This topic matters to labs, coders, and compliance staff who need to understand the Medicare-specific reporting framework for these services.

Article Sections

1. Turn to HCPCS Level II for Medicare

   Introduces the Medicare-specific coding approach for drug screening tests and contrasts it with the CPT framework used in other settings. It identifies the general HCPCS Level II options discussed in the article.

2. Know CLIA Certification

   Explains how CLIA complexity categories are used to classify laboratory testing for billing purposes. It also describes the broader test complexity groupings and the role of laboratory methodology.

3. Beware of These Compliance Issues

   Covers general claim-processing concerns for Medicare drug screening, including units of service, bundling edits, and modifier handling. The section emphasizes compliance considerations for laboratory billing.